Kelly Jason R bought DNA
April 8, 2026 · Form 4 insider transaction
Kelly Jason R bought 212,949 shares of Ginkgo Bioworks Holdings, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
212,949
Price
N/A
Total value
N/A
InsiderKelly Jason R
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateApril 8, 2026
Filing dateApril 10, 2026
Shares owned after523,265
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.